Not all partial dopamine D2 receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse

Hugo Geerts
  • Neuropsychiatric Disease and Treatment, September 2010, Taylor & Francis
  • DOI: 10.2147/ndt.s12460

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Hugo Geerts